SCHEMBL601975

SCHEMBL601975

O=P(O)(O)CCC(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346946 0.82 TYMS (0.58)
SCHEMBL1396820 0.79 ENPEP (0.46)
SCHEMBL242286 0.78 ENPEP (0.50)
SCHEMBL3420165 0.77
SCHEMBL5720460 0.75 FDPS (0.57)
SCHEMBL1231383 0.75 THRB (0.46)
SCHEMBL1230857 0.75 THRB (0.46)
SCHEMBL11660658 0.75 ALDH1A1 (0.48)
SCHEMBL6232069 0.75 ENPEP (0.43)
SCHEMBL701768 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994013688-A1 DNA-ARMED RIBOZYMES AND MINIZYMES GENE SHEARS PTY. LIMITED (AU) 1994-06-23 WO claimed
EP-3980502-A1 HEAT-SENSITIVE AQUEOUS POLYURETHANE DISPERSION AND METHOD FOR PREPARING THE SAME Dow Global Technologies LLC (US) 2022-04-13 EP disclosed
EP-3938417-A1 WATERBORNE POLYURETHANE DISPERSION AND METHOD FOR PREPARING SAME Dow Global Technologies LLC (US) 2022-01-19 EP disclosed
EP-3938413-A1 WATERBORNE POLYURETHANE DISPERSION AND METHOD FOR PREPARING SAME Dow Global Technologies LLC (US) 2022-01-19 EP disclosed
WO-2020243899-A1 HEAT-SENSITIVE AQUEOUS POLYURETHANE DISPERSION AND METHOD FOR PREPARING THE SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2020-12-10 WO disclosed
WO-2020187336-A1 WATERBORNE POLYURETHANE DISPERSION AND METHOD FOR PREPARING SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2020-09-24 WO disclosed
WO-2020186377-A1 WATERBORNE POLYURETHANE DISPERSION AND METHOD FOR PREPARING SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2020-09-24 WO disclosed
WO-2020097839-A1 SYNTHETIC LEATHER ARTICLE AND METHOD FOR PREPARING THE SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2020-05-22 WO disclosed
WO-2020097838-A1 SYNTHETIC LEATHER ARTICLE AND METHOD FOR PREPARING SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2020-05-22 WO disclosed
US-9868955-B2 Human toll-like receptor inhibitors and methods of use thereof DYNAVAX TECHNOLOGIES CORPORATION (US) 2018-01-16 US disclosed
US-6555668-B2 Comprising a non-nucleotide in a single-stranded region; hammerhead ribozyme having a non-nucleotide in the catalytic core; synthesis of abasic ribonucleoside mimetics RIBOZYME PHARMACEUTICALS, INC. 2003-04-29 US disclosed
WO-2003000922-A2 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME DYNAVAX TECHNOLOGIES CORPORATION (US) 2003-01-03 WO disclosed
US-20020193579-A1 Non-nucleotide containing enzymatic nucleic acid RIBOZYME PHARMACEUTICALS, INC. 2002-12-19 US disclosed
US-6362323-B1 HAVING ACTIVITY TO CLEAVE AN RNA OR DNA MOLECULE RIBOZYME PHARMACEUTICALS, INC. 2002-03-26 US disclosed
US-6117657-A ENZYMATIC NUCLEIC ACID MOLECULE CONTAINING ONE OR MORE NON-NUCLEOTIDE MIMETICS, AND HAVING ACTIVITY TO CLEAVE AN RNA OR DNA MOLECULE RIBOZYME PHARMACEUTICALS, INC. (US) 2000-09-12 US disclosed
EP-0908464-A1 Process for the preparation of hydroxyphosphonates and their use as flame retardants in polymers BASF AKTIENGESELLSCHAFT (DE) 1999-04-14 EP disclosed
US-5891683-A Non-nucleotide containing enzymatic nucleic acid RIBOZYME PHARMACEUTICALS, INC. (US) 1999-04-06 US disclosed
EP-0799313-A2 METHOD AND REAGENT FOR TREATMENT OF ARTHRITIC CONDITIONS, INDUCTION OF GRAFT TOLERANCE AND REVERSAL OF IMMUNE RESPONSES RIBOZYME PHARMACEUTICALS, INC. (US) 1997-10-08 EP disclosed
WO-1996018736-A2 METHOD AND REAGENT FOR TREATMENT OF ARTHRITIC CONDITIONS, INDUCTION OF GRAFT TOLERANCE AND REVERSAL OF IMMUNE RESPONSES RIBOZYME PHARMACEUTICALS, INC. (US) 1996-06-20 WO disclosed
WO-1994013688-A1 DNA-ARMED RIBOZYMES AND MINIZYMES GENE SHEARS PTY. LIMITED (AU) 1994-06-23 WO disclosed